Breathtaking Innovation
When lung infections are on the line, every minute counts.
The rapid Allora BreathTest™, currently in late-stage clinical development, can detect lung bacterial infection in 10 minutes.
When lung infections are on the line, every minute counts.
The rapid Allora BreathTest™, currently in late-stage clinical development, can detect lung bacterial infection in 10 minutes.
The only test that has the potential to differentiate a virulent bacterial infection from strep pneumonia and viral lung infection.
A Value-Based, Cost Advantaged Product would be a Win for Patient, Doctor, Hospital and Payer
ABT Portfolio | ABT Indications | IDE/Pivotal | |
---|---|---|---|
Ventilator Associated Pneumonia | 2023 | ||
Post-Covid 19 Bronchiectasis | Investigator Sponsored | ||
Chronic Obstructive Pulmonary Disease (COPD) |
Investigator Sponsored | ||
Community-Acquired Pneumonia (CAP) |
Investigator Sponsored | ||
Cystic Fibrosis | Investigator Sponsored | ||
Tuberculosis | Investigator Sponsored | ||
Aspergillus/Coccii Fungus | Investigator Sponsored | ||
Clostridium Difficile (C. diff) | Developmental |